9amHealth Review
GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: branded GLP-1s within a full cardiometabolic care program
9amHealth scores highest on the strength of its clinical program — drug options and dosing support.
What the plan covers
Medication
Not disclosed
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
9amHealth is a cardiometabolic telehealth platform offering whole-body care, including weight management with FDA-approved branded GLP-1 medications such as Wegovy, Zepbound, and Saxenda, plus FDA-approved generics. The care team includes physicians, board-certified obesity specialists (DABOM), endocrinologists, dietitians, and pharmacists, and it helps navigate insurance approvals through employer and state-plan partnerships. It doesn't publish a self-pay price on its website, and medication is billed separately from the care program.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to 9amHealth
Enhance MD
Best for: lab-monitored compounded GLP-1 with mandatory video visit
Editorial score · methodology
MEDVi
Best for: switching between compounded and brand-name GLP-1 through one provider
Editorial score · methodology
DudeMeds
Best for: men seeking no-fee compounded or brand-name GLP-1 injections
Editorial score · methodology
9amHealth at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Wegovy, Zepbound
- FDA status
- No FDA warning letter on record
How we scored 9amHealth
Each dimension is scored algorithmically from 9amHealth’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.8/109amHealth does not post a standard monthly cash price up front, so cost transparency is limited — confirm the ongoing rate before you commit.
Effectiveness25%
8.8/109amHealth offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.9/10Online intake and platform experience; 7 platform features disclosed.
Trust & Safety15%
7.7/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.1/109amHealth's exact state footprint isn't published — confirm coverage in your state before signing up. Insurance pathways are offered for eligible patients.
Support10%
6.6/109amHealth provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this 9amHealth review
Last checked October 2026- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with 9amHealth
We walked 9amHealth’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Complete a whole-health evaluation online.
- 2Receive a personalized care plan.
- 3Get prescriptions and labs approved by the care team.
- 4Prescriptions go to your home or your preferred pharmacy, with ongoing expert support.
- No program or medication price is shown on the public site or before account creation.
- Specialized care spans weight loss, diabetes, and heart health.
- At-home lab tests and access to specialists are part of the program.
- Cites a 17.6% weight reduction over 12 months for members using GLP-1s.
- The Help Center lists an email address and a phone line, (202) 932-9958.
9amHealth customer support
- Phone
- (202) 932-9958
GLP-1 medications 9amHealth offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
What we like
- Prescribes FDA-approved branded GLP-1s (Wegovy, Zepbound, Saxenda)
- Board-certified obesity specialists (DABOM), endocrinologists, dietitians, PharmDs
- Helps navigate insurance approvals; employer and state-plan partnerships
- Home lab draws available in some areas
- Prescriptions sent to your home or your preferred pharmacy
- Cardiometabolic whole-body care beyond weight loss
Watch-outs
- Medication coverage and GLP-1 access depend on insurance and BMI criteria
- No program or medication price published on the website
- Medication is billed separately from the care program
- Branded GLP-1s can be costly without insurance coverage
- State availability not enumerated on the public site
9amHealth: the insurance-first route to brand-name GLP-1s
Most of the telehealth brands in this category sell you a compounded vial and a price tag. 9amHealth is built on a different premise: it wants to get you the actual FDA-approved branded drug — Wegovy, Zepbound, or Saxenda — covered by your insurance, inside a broader cardiometabolic care program. If you have decent coverage and a qualifying BMI, that is genuinely one of the cheapest and safest ways to take a GLP-1. If you don't have coverage, this is probably not the provider for you, and it's honest about that. Below I break down how the model actually works and who it really fits.
How the pricing really works
9amHealth doesn't publish a price on its website. There's no pricing page, and no figure appears before you create an account, so you can't see what the program costs before you sign up. The company's own help material does make one thing clear: medication costs are not included in the program fee. The care program covers specialist appointments, lab work, connected devices and a personalized care plan; the drug is a separate bill.
So there are two separate cost questions. The program covers the care. Whether a branded GLP-1 lands in your hands affordably depends on your insurance approving it, and that approval hinges on clinical criteria (more on that below). When coverage comes through, your total out-of-pocket can be very low — a copay rather than a cash price. When it doesn't, a branded GLP-1 can run well over a thousand dollars a month at list, and 9amHealth doesn't paper over that with a discounted cash program the way compounding-focused competitors do. For context, the typical monthly cost across the providers we track sits around $179. A covered branded prescription can undercut that substantially, but only if the insurance piece works out.
How we get the category median: $179 is the middle value of the cheapest ongoing monthly price (not a first-month promo) at each of the 508 GLP-1 providers we track.
What's genuinely included
- Specialist visits — physicians plus board-certified obesity medicine specialists (DABOM), endocrinologists, dietitians (RDNs), and pharmacists (PharmDs)
- At-home lab tests, with home blood draws available in some areas
- Connected devices for tracking cardiometabolic markers
- Personalized care plans that pair medication with lifestyle changes
- Prescriptions sent to your home or your preferred pharmacy, billed separately
The medications: real branded GLP-1s, dispensed through pharmacy
This is the headline. 9amHealth prescribes FDA-approved branded GLP-1s — semaglutide as Wegovy, plus Zepbound and Saxenda — along with FDA-approved generics where appropriate. These are the same drugs studied in the major weight-loss trials, dispensed through standard pharmacy channels, not compounded in a 503-facility. For anyone wary of compounding pharmacies, that's a meaningful trust signal. The provider cites about 17.6% average weight loss with a GLP-1 over twelve months, in line with what you'd expect from branded therapy used consistently.
Because the model leans on insurance, a big part of the actual job here is navigating prior authorizations and coverage rules. 9amHealth says it works through employer plans, state plans (Georgia's state health benefit plan is named explicitly), and partnerships with Amazon and Lilly to widen access. That insurance-navigation muscle is the thing you're really paying the care team for.
Eligibility: this is where people get filtered out
Be clear-eyed about qualification. GLP-1 access through 9amHealth requires meeting clinical criteria — a BMI over 30, or over 27 with a weight-related comorbidity — and then your insurer signing off. That's standard obesity-medicine practice and it's the right way to prescribe these drugs, but it means 9amHealth is not a path to a GLP-1 if you're below those thresholds or want a cash-pay shortcut around insurance. Several people who'd get an easy yes from a compounding-first competitor will get a no here.
Who should choose it — and who should skip it
Choose 9amHealth if you have employer or government insurance (especially through one of its named partners), a qualifying BMI, and you want the real branded drug under genuine specialist oversight rather than a compounded alternative. The cardiometabolic framing is a real plus if your weight is tangled up with blood pressure, blood sugar, or cholesterol — this is whole-body care, not a weight-loss vending machine.
Skip it if you're uninsured or underinsured, if your BMI won't clear the bar, or if you simply want the lowest possible cash price with no insurance friction. Those shoppers are better served by a cash-pay compounding provider. Two other honest caveats. 9amHealth doesn't list its state availability on the public site, so confirm it serves your state before you commit. And it doesn't list any prices up front, for the program or the medication. Medication cost depends on your coverage, so you won't know your real number until the insurance review is done.
Trust, oversight, and safety
On the clinical side, this is one of the stronger setups in the category. The care team includes board-certified obesity medicine specialists, endocrinologists, registered dietitians, and pharmacists — credentials that go beyond the single-prescriber model some telehealth brands run on. There are no FDA warning letters on file for this provider, and because it dispenses branded, FDA-approved drugs through pharmacy rather than compounding, it sidesteps the quality questions that hang over parts of this market. The gaps are state coverage and pricing, neither of which is publicly listed. You can read how we weigh these factors in our scoring methodology.
Bottom line
9amHealth is the provider to beat if you're insured and want a real branded GLP-1 inside a serious, specialist-led care program rather than a quick compounded script. When your coverage cooperates, the value is hard to match: a branded drug at a copay, plus labs, devices and obesity specialists. The program fee isn't published, though, so ask for it before you commit. The whole proposition lives or dies on that insurance piece, and the provider is upfront that medication access is gated by coverage and BMI. Confirm your plan and your state first; if both line up, this is a standout choice.
If you're weighing alternatives, Collective ($59/month) is one of the closest options we track to 9amHealth.
The Bottom Line
9amHealth scores highest on the strength of its clinical program — drug options and dosing support.
Ready to start with 9amHealth?
See current pricing and start your free consultation.
9amHealth might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this 9amHealth review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See 9amHealth's current pricing
Start your free consultation to check eligibility and today's price.